newsfilter
← Latest News
GlobeNewswire·

Immutep Receives A$2.16 million French R&D Tax Incentive

SYDNEY, AUSTRALIA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), a clinical-stage immunotherapy company targeting cancer and autoimmune